Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 935

L-carnitine-L-tartrate

Intended Use: Intended for use as an ingredient in non-exempt formulas for term infants at a level of 11 mg/L of the infant formula as consumed.
Basis: Scientific procedures
Notifier: Ausnutria B.V.
Notifier Address: Dokter van Deenweg 150
8025 BM Zwolle
The Netherlands
GRAS Notice (releasable information): GRN 935 (in PDF) (10 MB)
Date of closure: Nov 30, 2020
FDA's Letter: At the notifier's request, FDA ceased to evaluate this notice (in PDF) (242 kB)
Resubmitted: 993
-
-